A nurse is providing teaching to a client who has diabetes mellitus about the glycosylated hemoglobin blood test. Which of the following statements by the client indicates an understanding of this test?

A. Negative clonus: Monitoring for a negative clonus is appropriate as it indicates effective control of neuromuscular excitability and seizure prevention in clients receiving magnesium sulfate for preeclampsia. A negative clonus response suggests that the magnesium sulfate is effectively managing the risk of seizures.

B. BP 150/92 mm Hg: While blood pressure management is important in preeclampsia, a blood pressure of 150/92 mm Hg indicates hypertension, which is not a desired therapeutic effect when managing preeclampsia with magnesium sulfate.

C. Pulse rate 100/min: A pulse rate of 100/min is not a specific therapeutic effect of magnesium sulfate and can indicate tachycardia, which might require further evaluation rather than being a target for monitoring.

D. Flushed face: A flushed face may occur as a side effect of magnesium sulfate infusion, but it is not a therapeutic effect. It does not indicate that the medication is working to control the symptoms of preeclampsia.

A) Administering the medication at bedtime is not advisable because methylphenidate is a stimulant that can cause insomnia. It's typically recommended to give it in the morning or after breakfast to help manage symptoms during the day while minimizing sleep disturbances.

B) Administering the medication after breakfast is the best practice. Taking methylphenidate with food can help reduce gastrointestinal side effects and improve the medication's effectiveness throughout the school day. This timing also aligns with the medication's action profile to support focus and attention during daytime activities.

C) While monitoring sodium intake can be important for overall health, there is no specific requirement for children taking methylphenidate to avoid excess sodium. Instead, a balanced diet is generally encouraged, and any dietary changes should be discussed with a healthcare provider.

D) Foods containing tyramine are typically associated with monoamine oxidase inhibitors (MAOIs) and are not specifically a concern with methylphenidate. Therefore, advising avoidance of tyramine-rich foods is not relevant in this context, and the focus should be on proper medication management and monitoring for side effects.